Targeting KRASG12C in colorectal cancer: the beginning of a new era
2022 · ESMO Open · 34 citations
https://doi.org/10.1016/j.esmoop.2022.100745
D
Davide Ciardiello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
191
Papers
3.8K
Citations
31
h-index
73
i10-index
Davide Ciardiello is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Genetic factors in colorectal cancer & Cancer Genomics and Diagnostics. The author has an h-index of 31, co-authored 163 publications.
ORCID: 0000-0003-1826-0305Papers by this author
worksRetrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
2021 · Clinical Colorectal Cancer · 22 citations
https://doi.org/10.1016/j.clcc.2021.06.002
Comprehensive Review on the Clinical Relevance of Long Non-Coding RNAs in Cutaneous Melanoma
2021 · International Journal of Molecular Sciences · 18 citations
https://doi.org/10.3390/ijms22031166
Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM)
2022 · ESMO Open · 11 citations
https://doi.org/10.1016/j.esmoop.2022.100567
BRAFV600E mutant metastatic colorectal cancer: Current advances in personalized treatment and future perspectives
2025 · Cancer Treatment Reviews · 11 citations
https://doi.org/10.1016/j.ctrv.2025.102905
Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape
2024 · ESMO Gastrointestinal Oncology · 7 citations
https://doi.org/10.1016/j.esmogo.2024.100048
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat